XNAS
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2024-08-13 | FY 2024 | — | -0.57 | — | $0 | — | -0.01% | +3.00% | +3.50% |
| 2023-05-17 | FY 2022 | — | -0.01 | — | $0 | — | -1.72% | -19.54% | -26.21% |
Showing last 2 quarters.